Adrenal atrophy at autopsy in two asthmatic children

Area of Science:

• Pediatric Endocrinology
• Pulmonology
• Pathology

Background:

• Asthma is a chronic respiratory disease affecting children worldwide.
• Corticosteroids are a cornerstone in managing pediatric asthma, reducing inflammation and exacerbations.
• Long-term corticosteroid use, especially in early life, necessitates careful monitoring for potential side effects.

Observation:

• Autopsy findings revealed significant adrenocortical atrophy in two children who died from status asthmaticus.
• Both children had a history of prolonged exposure to various forms of corticosteroids since infancy, including inhaled, oral, parenteral, and topical preparations.
• This represents a previously undescribed association between corticosteroid treatment for asthma and adrenal gland atrophy in pediatric patients.

Findings:

• The study demonstrates a potential link between extensive corticosteroid use in pediatric asthma and the development of adrenocortical atrophy.
• The atrophy observed was significant enough to be detected post-mortem, suggesting a substantial impact on adrenal function.
• While overt adrenal insufficiency was not explicitly stated, the atrophy implies compromised adrenal capacity.

Implications:

• The findings suggest that the increasing use of corticosteroids in managing pediatric asthma may lead to subclinical or overt adrenal atrophy.
• This condition could have significant implications for patient morbidity and mortality, particularly during stressful events or illness.
• Further research is warranted to elucidate the prevalence, clinical significance, and optimal management strategies for corticosteroid-induced adrenal atrophy in children with asthma.